Manifestations of SIV-induced ocular pathology in Macaque monkeys

Journal of Neuro-AIDS

Volumn 2, Issue 4, 2004, Pages 1-13

  Johnson, J K ^a,c   Warren, K A ^a   Berman, N E J ^a,d   Narayan, O ^a   Stephens, E B ^a   Joag, S V ^a   Raghavan, R ^a   Marcario, J K ^a,b   Cheney, P D ^a,b  

^a Department of Anatomy and Cell Biology ^*

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c Deptartment Molecular Biosciences   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; HIV; Retinopathy; SIV

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MALE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; POLYMERASE CHAIN REACTION; RETINA HEMORRHAGE; RETINOPATHY; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; EYE DISEASES; FUNDUS OCULI; MACACA MULATTA; RETINA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 24344505053     PISSN: 10697438     EISSN: None     Source Type: Journal    
DOI: 10.1300/J128v02n04_01     Document Type: Article

References (47)

1. DiLoreto D Jr., Epstein LLLG, Lazar ES, Britt WJ, del Cerro M. Cyotomegalovirus infection of human retinal tissue: an in vivo model. Lab. Invest. 1994; 71:141-148.
2. Joag SV, Stephens EB, Adams RJ, Foresman L, Narayan O. Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology. 1994; 200:436-446.
3. Desrosiers RC. The simian immunodeficiency viruses. Ann. Rev. Immunol. 1990; 8:557-578.
4. McClure HM, Anderson DC, Fultz PN, Ansari AA, Lockwood E, Brodie A. Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet. Immunol. Immunopathol. 1989; 21:13-24.
5. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988; 239:617-622.
6. Kinter A, Fauci AS. Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement. Immunol. Res. 1996; 15:1-15.
7. Chakrabarti L, Guyader M, Alizon M, Daniel MD, Daniel RC, Desrosiers RC, Tiollais P, Sonigo P. Sequences of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 1987; 328:543-547.
8. McClure HM, Anderson DC, Ansari AA, Klumpp SA. The simian immunodeficiency virus infected macaque: a model for pediatric AIDS. Pathologic Biologie 1992; 40:694-700.
9. Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989; 339:389-392.
10. Joag SV, Foresman L, Stephens EB, Zhao LJ, Adany I, Pinson DM, McClure HM, Narayan O. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 1996; 70:3189-3197.
11. Stephens EB, Liu ZQ, Zhu GW, Adany I, Joag SV, Foresman L, Berman NE, Narayan O. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys. Virology 1995; 213:600-614.
12. mac infection in the brain. J. NeuroVirol. 1995; 1:78-91.
13. Sharma DP, Zink MC, Anderson M, Adams R, Clements JE, Joag SV, Narayan O. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocyte-tropic parental virus: pathogenesis of infection in macaques. J. Virology 1992; 66:3550-3556.
14. Koenig SC, Gendelman ME, Orenstain, JM, Dalccanto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233:1089-1093.
15. Scholz M, Doerr HW, Cinatl J. Human cytomegalovirus retinitis: pathogenicity, immune evasion, and persistence. Trends Microbiol. 2003; 11:171-178.
16. Henderly DE, Freeman WR, Smith RE, Causey D, Rao NA. Cytomegalovirus retinitis as the initial manifestation of the acquired immune deficiency syndrome. Amer. J. Ophthalmology 1987; 103:316-320.
17. Fabricius, E-M. [Why are AIDS patients frequently visually impaired?] In German. Therapeutische Umschau. 1996; 53:49-57.
18. Hansen LL. [Retinal diseases in AIDS] In German. Ophthalmologe 1993; 90:239-249.
19. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989; 96:1092-1099.
20. Fabricius E-M, Moller AA, Prantl F. [Disorders of the afferent visual pathway in HIV infection. 1. Optic nerve and 2. Visual pathways/visual cortex] In German. Fortschr-Ophthalmol. 1991; 88:721-730.
21. Geier SA, Perro C, Klauss V, Naber D, Kronawitter U, Bogner JR, Goebel FD, Lund OE, Hippius H. HIV-related ocular microangiopathic syndrome and cognitive functioning. J. Acq. Imm. Def. Synd. 1993; 6:252-258.
22. Mansour AM, Uchida T, Rodenko G, Dutt R. Ocular-systemic interrelationships in acquired immunodeficiency syndrome. Int. J. STD and AIDS 1991; 2:25-29.
23. Mansour AM, Rodenko G, Dutt R. Half-life of cotton-wool spots in the acquired immunodeficiency syndrome. International Journal of STD and AIDS 1990; 1:132-133.
24. Kestelyn P, Taelman H, Bogaerts J, Kagame A, Abdel-Aziz M, Batungwanayo J, Stevens AM, Van de Perre P. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 1993; 116:721-727.
25. Johnson JK, Warren KA, Stephens EB, Narayan O, Cheney PD, Engelbrecht NE, Berman NEJ. Ocular lesions and altered expression of Bcl-2 in the SIV-infected macaque retina: an animal model of AIDS. Soc. Neurosci. Abstracts 1996; 22:2016.
26. Wurdeman AE, Rao NS, Tenhula WN, Foote T, Sadun AA. Optic nerve morphometry following axonal degeneration from SAIDS in rhesus monkeys. Curr. Eye Res. 1994; 13:619-623.
27. Conway MD, Didier P, Insler MS. Ocular manifestation of simian immunodeficiency syndrome (SAIDS). Curr. Eye Res. 1990; 9:759-770.
28. Berman NEJ, Johnson JK, Raymond L, Stephens EB, Joag S, Narayan O. Pathogenesis of the AIDS dementia complex in the SIV model. Journal of the European College of Neuropsychopharmacology 1996; 6:22.
29. Vitkovic L, Stover E, Koslow SH. Animal models recapitulate aspects of HIV/CNS disease. AIDS Res. Hum. Retroviruses. 1995; 11:753-759.
30. Clements JE, Anderson MG, Zink MC, Joag SV, Narayan O. The SIV model of AIDS encephalopathy. Role of neurotropic viruses in diseases. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 1994; 72:147-57.
31. Sharer LR. Neuropathology and pathogenesis of SIV infection of the central nervous system. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 1994; 72:133-145.
32. Anderson MG, Hauer D, Sharma DP, Joag SV, Narayan O, Zink MC, Clements JE. Analysis of envelope changes acquired by SIVmac239 during neuroadaptation in rhesus monkeys. Virology. 1993; 195:616-626.
33. Mahurkar AA, Vivino MA, Trus BL, Kuehl EM, Datiles MB, Kaiser-Kupfer MI. Constructing retinal fundus photomontages. A new computer-based method. Invest. Ophthalmol. Vis. Sci. 1996; 37:1675-1683.
34. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globulin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230:1350-1354.
35. Saiki RK, Gelfand D, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487-491.
36. Regier DA, Desrosiers RC. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 1990; 6:1221-1231.
37. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1983; 132:6-13.
38. Alcendor DJ, Barry PA, Pratt-Lowe E, Luciw PA. Analysis of the rhesus cytomegalovirus immediate-early gene promoter. Virology 1993; 194:815-821.
39. Franchini G, Gurgo C, Guo HG, Gallo RC, Collalti E, Fargnoli KA, Hall LF, F. W-S, Reitz MS. Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature 1987; 328:539-543.
40. Mankowski JL, Spelman JP, Ressetar HG, Strandberg JD, Laterra J, Carter DL, Clements JE, Zink MC. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virology 1994; 68:8202-8208.
41. Harkins T. Noninfectious retinopathy. Optom. Vis. Sci. 1995; 72:302-304.
42. Jabs DA. Ocular manifestations of HIV infection. Trans. Am. Ophthalmol. Soc. 1995; 93:623-683.
43. Holland GN, Pepose JS, Pettis TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome; ocular manifestations. Ophthalmology 1983; 90:859-873.
44. Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/Delta. Vet. Pathol. 1988; 25:456-467.
45. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clements M, Goudsmit J. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 1991; 180:583-590.
46. Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis, MD, Friedberg D. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch. Ophthalmol. 2003; 121:99-107.
47. Langford TD, Letendre SL, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003; 13:195-210.